Status:
COMPLETED
Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Thalassemia Alpha
Hemolytic Anemia
Eligibility:
All Genders
Up to 20 years
Brief Summary
The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.
Detailed Description
Fifty children and adolescents diagnosed as having alpha thalassemia will be studied, the clinical characteristics and hematology analysis will be summarized.
Eligibility Criteria
Inclusion
- All the patients that were studied at the pediatric hematology unit ant the Ha'Emek Medical Center
Exclusion
- None
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00971984
Start Date
October 1 2009
End Date
April 1 2012
Last Update
September 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, Israel, 18101